《亚洲股市》港日台韩股挫2.4%-3% 惟泰国及菲律宾逆升0.4%-0.6%
全球多国债息明显上升,其中美国十年期债息昨晚曾触及1.6%为去年中以来首见,触及市场忧虑情绪。亚太区主要股市跟随美股下挫,日经曾低见29,219,现造29,323,急吐844点或2.8%;台湾加权指数及韩股也急吐2.4%及3%,分别报16,060及3,007。澳洲200回吐1.9%报6,704;印度孟买指数曾急吐2%低见49,950,现造50,258,回吐1.5%。沪指及深成半日收3,519及14,534,挫1.8%及2%。
恒指今早在重磅新经济股、手机和濠赌股,以港交所(00388.HK及药明生物(02269.HK)捱沽主导,曾急挫927点,低见29,147守稳本月初低位,半日收29,342,回吐731点或2.4%。不过,泰股续弹0.4%报1,496;菲股假後重开回升0.6%报6,798。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.